Radiation recall dermatitis induced by sorafenib
نویسندگان
چکیده
منابع مشابه
Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
We report on a 63-year-old man with a history of hepatitis B virus-related hepatocellular carcinoma with a thrombus extending into the inferior vena cava, who received image-guided stereotactic body radiation therapy (SBRT) with helical tomotherapy, followed by sorafenib. A total tumor dose of 48 Gy was delivered by 6 fractions within 2 weeks. The tumor responded dramatically, and the patient t...
متن کاملSorafenib induced radiation recall dermatitis after spine radiosurgery.
Radiation recall dermatitis has been documented to occur in previously irradiated skin (within the radiation port) the administration of some chemotherapeutic agents. Clinically, it can occur weeks or months after radiation therapy, and resembles the appearance of acute radiation skin reaction. The patterns of the reaction correspond with radiation fields and skin doses. We report a case of rec...
متن کاملTamoxifen-induced radiation recall dermatitis.
To the Editor: Radiation recall dermatitis is a phenomenon seen in patients who have received radiation therapy followed by chemotherapy. Tamoxifen, a selective estrogen receptor (ER) modulator, has been implicated in three cases of radiation recall dermatitis (1–3). We report a fourth case, which we believe to be the first reaction documented in the United States. An 88-year-old woman was diag...
متن کاملSorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radiotherapy (RT) for the chest wall mass. Sorafenib at 400 mg twice daily was begun on the day follow...
متن کاملRadiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma
Sorafenib is widely used for unresectable and metastatic hepatocellular carcinomas. Radiation recall dermatitis (RRD) is an acute inflammatory reaction confined to previously irradiated skin that occurs after the administration of certain drugs. RRD after sorafenib treatment is rare; five cases have been reported thus far. We describe a 44-year-old man irradiated for chest wall bone metastasis ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Strahlentherapie und Onkologie
سال: 2016
ISSN: 0179-7158,1439-099X
DOI: 10.1007/s00066-016-0950-7